Kelly Jason R — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Kelly Jason R is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $1.37M.
Profile
Jason R. Kelly is a prominent executive in the biotechnology sector, currently serving as the CEO of Ginkgo Bioworks Holdings, Inc., a company known for its innovative work in synthetic biology. Under his leadership, Ginkgo Bioworks has made significant advancements in the field, focusing on programming cells to produce a wide range of products. Kelly has a strong background in both science and business, which has positioned him well to lead the company in its mission to make biology easier to engineer.
Role
See remarks, Director
Notability
70/100
Board memberships
Ginkgo Bioworks Holdings, Inc.
Awards & honors
Led Ginkgo Bioworks to become a leader in synthetic biology
Expanded partnerships with major companies in various industries
Jason R. Kelly is a prominent executive in the biotechnology sector, currently serving as the CEO of Ginkgo Bioworks Holdings, Inc., a company known for its innovative work in synthetic biology. Under his leadership, Ginkgo Bioworks has made significant advancements in the field, focusing on programming cells to produce a wide range of products. Kelly has a strong background in…
Has Kelly Jason R been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.37M) across all tracked filings.
Where can I see all of Kelly Jason R's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
